EMAIL THIS PAGE TO A FRIEND

PloS one

Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptor.


PMID 25738827

Abstract

Serum amyloid A3 (SAA3) possesses characteristics distinct from the other serum amyloid A isoforms, SAA1, SAA2, and SAA4. High density lipoprotein contains the latter three isoforms, but not SAA3. The expression of mouse SAA3 (mSAA3) is known to be up-regulated extrahepatically in inflammatory responses, and acts as an endogenous ligand for the toll-like receptor 4/MD-2 complex. We previously reported that mSAA3 plays an important role in facilitating tumor metastasis by attracting circulating tumor cells and enhancing hyperpermeability in the lungs. On the other hand, human SAA3 (hSAA3) has long been regarded as a pseudogene, which is in contrast to the abundant expression levels of the other isoforms. Although the nucleotide sequence of hSAA3 is very similar to that of the other SAAs, a single oligonucleotide insertion in exon 2 causes a frame-shift to generate a unique amino acid sequence. In the present study, we identified that hSAA3 was transcribed in the hSAA2-SAA3 fusion transcripts of several human cell lines. In the fusion transcript, hSAA2 exon 3 was connected to hSAA3 exon 1 or hSAA3 exon 2, located approximately 130kb downstream from hSAA2 exon 3 in the genome, which suggested that it is produced by alternative splicing. Furthermore, we succeeded in detecting and isolating hSAA3 protein for the first time by an immunoprecipitation-enzyme linked immune assay system using monoclonal and polyclonal antibodies that recognize the hSAA3 unique amino acid sequence. We also demonstrated that hSAA3 bound oxidized low density lipoprotein receptor (oxLDL receptor, LOX-1) and elevated the phosphorylation of ERK, the intracellular MAP-kinase signaling protein.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

09743
3,3′,5,5′-Tetramethylbenzidine, standard for GC
C16H20N2
32883
4-tert-Octylphenol monoethoxylate solution, 1 μg/mL in acetone, analytical standard
C16H26O2
32882
4-tert-Octylphenol monoethoxylate solution, 10 μg/mL in acetone, analytical standard
C16H26O2
14339
Bicinchoninic acid disodium salt hydrate, ≥99.0% (HPLC)
C20H10N2Na2O4 · xH2O
SRP6378
CD36 human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
C5914 Cell Dissociation Solution Non-enzymatic 1x, Prepared in phosphate buffered saline without calcium and magnesium, sterile-filtered, BioReagent, suitable for cell culture
D0700000
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
1176007
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
C22H29FO5
46165
Dexamethasone, VETRANAL, analytical standard
C22H29FO5
31375
Dexamethasone, tested according to Ph.Eur.
C22H29FO5
PHR1526
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
C22H29FO5
Y0001593
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
Y0001177
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
PHR1359
Glutathione, Pharmaceutical Secondary Standard; Certified Reference Material
C10H17N3O6S
Y0000517
Glutathione, European Pharmacopoeia (EP) Reference Standard
C10H17N3O6S
54461
HEPES, ≥99.0% (T)
C8H18N2O4S
PHR1428
HEPES, Pharmaceutical Secondary Standard; Certified Reference Material
C8H18N2O4S
215155
Hydrazine, anhydrous, 98%
H4N2
433632
Hydrazine solution, 1.0 M in THF
H4N2
309400
Hydrazine solution, 35 wt. % in H2O
H4N2
751855
Hydrazine solution, 1 M in acetonitrile
H4N2
L2880 Lipopolysaccharides from Escherichia coli O55:B5, purified by phenol extraction
71383
Sodium chloride, tested according to Ph.Eur.
ClNa
71387
Sodium chloride, certified reference material for titrimetry, certified by BAM, according to ISO 17025, ≥99.5%
ClNa
PHR1321
Sodium chloride, Pharmaceutical Secondary Standard; Certified Reference Material
ClNa
71177
Sodium standard for AAS, ready-to-use, traceable to BAM, in H2O
ClNa
T3258
Tetracycline, ≥88.0% (HPLC)
C22H24N2O8 · xH2O
87128
Tetracycline, ≥98.0% (NT)
C22H24N2O8 · xH2O